Prostate Cancer - Results from #220

Daily Physical Activity Monitoring in Older Adults with Metastatic Prostate Cancer on Active Treatment: Feasibility and Associations with Toxicity - Beyond the Abstract September 20, 2023

Efficacy of National Comprehensive Cancer Network Guidelines in Identifying Pathogenic Germline Variants Among Unselected Patients with Prostate Cancer: The PROCLAIM Trial - Beyond the Abstract September 18, 2023

A Phase I Trial of Focal Salvage Stereotactic Body Radiation Therapy for Radiorecurrent Prostate Cancer - Beyond the Abstract September 14, 2023

Addition of Cribriform and Intraductal Carcinoma Presence to Prostate Biopsy Reporting Strengthens Pretreatment Risk Stratification Using CAPRA and NCCN Tools - Beyond the Abstract September 13, 2023

Location Matters: Could Nucleo-Cytoplasmic ErbB3 Shift the Balance from Treatment Resistance to Treatment Efficacy in Castration-Resistant Prostate Cancer? - Beyond the Abstract September 13, 2023

"TREXIT 2020": Why the Time to Abandon Transrectal Prostate Biopsy Starts Now - Beyond the Abstract September 11, 2023

Assessing the Feasibility of Utilizing Artificial Intelligence-Segmented Dominant Intraprostatic Lesion for Focal Intraprostatic Boost with External Beam Radiation Therapy - Beyond the Abstract September 5, 2023

Personalizing Approaches to the Management of Metastatic Hormone Sensitive Prostate Cancer: Role of Advanced Imaging, Genetics and Therapeutics - Beyond the Abstract August 31, 2023

Fragmentomic Analysis of Circulating Tumor DNA Targeted Cancer Panels - Beyond the Abstract August 29, 2023

Androgen Receptor Blockade Resistance with Enzalutamide in Prostate Cancer Results in Immunosuppressive Alterations in the Tumor Immune Microenvironment - Beyond the Abstract August 29, 2023

Lymphotropic Pattern of Prostate-Specific Membrane Antigen-Detected Metastases Among Biochemically Recurrent Radical Prostatectomy Patients with Cribriform Disease - Beyond the Abstract August 28, 2023

Prospective Validation Study of a Novel Integrated Pathway Based on Clinical Features, Magnetic Resonance Imaging Biomarkers, and MicroRNAs for Early Detection of Prostate Cancer - Beyond the Abstract August 25, 2023

Is Cribriform Pattern in Prostate Biopsy a Risk Factor for Metastatic Disease on 68Ga-PSMA-11 PET/CT? - Beyond the Abstract August 24, 2023

Gallium-68 Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography in Active Surveillance for Prostate Cancer Trial (PASPoRT) - Beyond the Abstract August 23, 2023

A VISION Substudy of Reader Agreement on 68Ga-PSMA-11 PET/CT Scan Interpretation to Determine Patient Eligibility for 177Lu-PSMA-617 Radioligand Therapy - Beyond the Abstract August 22, 2023

Impact of 18F-Fluciclovine PET/CT on Plans for Androgen Deprivation Therapy in Patients with Biochemical Recurrence of Prostate Cancer: Data Analysis from Two Prospective Clinical Trials - Beyond the Abstract August 17, 2023

Protocol of a Multicentre Randomised Controlled Trial Assessing Transperineal Prostate Biopsy to Reduce Infectious Complications - Beyond the Abstract August 17, 2023

Intermediate Grade Prostate Cancer and Risk for Adverse Pathology Radical Prostatectomy: Implications for Partial Gland Ablation Case Selection - Beyond the Abstract August 15, 2023

Transcriptomic and Clinical Heterogeneity of Metastatic Disease Timing Within Metastatic Castration-Sensitive Prostate Cancer - Beyond the Abstract August 9, 2023

The Clinical Significance of Maximum Tumor Diameter on MRI in Men Undergoing Radical Prostatectomy or Definitive Radiotherapy for Locoregional Prostate Cancer - Beyond the Abstract August 9, 2023

Page 12 of 62